Wednesday, January 28, 2009

Byetta अमेरिकी एफडीए चेतावनी

Byetta
अमेरिकी एफडीए चेतावनी
मंगलवार 16 अक्टूबर, 2007

अमेरिकी खाद्य एवं औषधि प्रशासन (एफडीए) , मधुमेह दवा Byetta (exenatide) के लिए एक चेतावनी जारी की है.
टाइप 2 मधुमेह के लिए Byetta एक injectable दवा निर्धारित है.

Byetta, अप्रैल 2005 में बाजार यह व्यापक रूप से टाइप 2 मधुमेह के साथ लोगों में रक्त शर्करा का स्तर के प्रबंधन के लिए निर्धारित है. यह आमतौर पर मौखिक दवाओं के साथ, ताकि बेहतर नियंत्रण प्राप्त किया जा सकता है निर्धारित है.

दिसम्बर में, 2006, चिकित्सा समाचार आज वह एक आधा मिलियन लोगों की संख्या बढ़ रही है कि समय से साथ Byetta निर्धारित हुए थे.

Pancreatitis के तीस मामलों को एफडीए द्वारा की समीक्षा की गई है. इस एफडीए कुछ pancreatitis के मामलों की Byetta के प्रयोग से जुड़े होने की घटना को समझता है. 30 मामलों का आधे से ज्यादा एक लाख Byetta प्रयोक्ताओं की तुलना में, एक बहुत छोटी संख्या है, लेकिन Amylin फर्माश्युटिकल, Inc को एफडीए का पालन करेंगे और "सावधानियों में तीव्र pancreatitis के बारे में जानकारी जोड़ Byetta के लेबल का" अनुभाग.

Byetta लेना बंद न करें. इस एफडीए कि डॉक्टरों Byetta लिख रोकने की सिफारिश नहीं है. इस दवा को ज्यादातर लोगों के लिए 2 मधुमेह के प्रकार के उपचार में सफल रहा है. यदि आप अपने डॉक्टर के साथ उन पर चर्चा Byetta लेने के बारे में चिंता है.

क्या pancreatitis के लक्षण हैं?

* ऊपरी पेट में अचानक दर्द है, कभी कभी गंभीर,. दर्द के पीछे या सीने को प्रसारित कर सकते हैं.
* मतली और उल्टी
* बुखार
कोमलता के साथ * सूजन पेट,

Tuesday, October 14, 2008

Critical tool

Your Goal HbA1c:Green Zone: Great Control


· HbA1c is under 7%____
· Average blood sugars typically under 150
· Most fasting blood sugars under 140
Green Zone Means
· Your blood sugars are under control
· Continue taking your medications as ordered
· Continue routine blood glucose monitoring
· Follow healthy eating habits
· Keep all physician appointments
Yellow Zone: Caution



· HbA1c between _7%___ and _9%___
· Average blood sugar between 150-210
· Most fasting blood glucose under 180

· Work closely with your health care team if you are going into the YELLOW zone
Yellow Zone Means:
· Your blood sugar may indicate that you need an adjustment of your medications
· Improve your eating habits
· Increase your activity level

· Call your physician, nurse, or diabetes educator if changes in your activity level or eating habits don’t decrease your fasting blood sugar levels.
Name:___________________________
Number:__________________________
Red Zone: Stop and Think

· HbA1c greater than 9%____
· Average blood sugars are over 210
· Most fasting blood sugars are well over 180

Call your physician if you are going into the RED zone
Red Zone Means:
You need to be evaluated by a physician.
If you have a blood glucose over ____ follow these instructions _____________
______________________________________________
· Call your physician

Physician___________________________
Number____________________________

Friday, August 29, 2008

Fat cells. derived stem cells further treatment of juvenile diabetes

About one year ago,

I received and e-mail from a father, asking about whether he should have a son take this treatment, which is being offered by a doctor from Gujarat.

that time. I had cautioned him to tread carefully and wait for and year or two before jumping. The gun.

although I had checked up the credentials of Dr.H.L.Trivedi.

his current and chills were impeccable,

but the lack of animal experimentation, and also lack of any published papers on this approach.

made me suspicious of the claims.

but I was waiting for a Publication in a peer reviewed Journal.

today while searching I came across the above article.

I am surprised that this has not caused a widespread sensation and the news media.

I have ordered for the article, once I have read article I will post my opinion.

I will also post a common man's explanation of what exactly was done, and what were the results.

and what we can expect in future.

the abstract of the article given below.

http://www.ncbi.nlm.nih.gov/pubmed/18555133

: Transplant Proc. 2008 May;40(4):1135-9.
Links
Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin.
Trivedi HL, Vanikar AV, Thakker U, Firoze A, Dave SD, Patel CN, Patel JV, Bhargava AB, Shankar V.
Department of Nephrology and Transplantation Medicine, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases and Research Centre, Dr. H.L. Trivedi Institute of Transplantation Sciences, Ahmedabad, Anand, India. ikdrcadl@sancharnet.in
BACKGROUND: Type 1 diabetes mellitus (DM) is an autoimmune disorder with disturbed glucose/insulin metabolism, which has no medical treatment other than life-long insulin therapy, despite which 30% of subjects develop organ failure. Herein we have reported the use of human adipose-tissue-derived, insulin-making mesenchymal stem cells (h-AD-MSC) transfused with unfractionated cultured bone marrow (CBM) in 5 insulinopenic DM patients. PATIENTS AND METHODS: Five (M:F, 2:3) insulinopenic DM patients of 0.6 to 10 years' duration, ages 14 to 28 years under treatment insulin (Human with 14-70 U/d) showed postprandial blood sugars between 156 to 470 mg%, glycosylated hemoglobin 6.8% to 9.9% and c-peptide levels of 0.02 to 0.2 ng/mL. They underwent intraportal administration of xenogeneic-free h-AD-MSC (mean dose = 1.5 mL; cell counts, 2.1 x 10(3)/muL). The CD45-/90+/73(+) cells (29.8/16.8%) showed c-peptide levels of 3.08 ng/mL, insulin level of 1578 micro IU/mL. The aliquot was supplemented with CBM (mean dose 94 mL with cell counts: 18.7 x 10(3)/microL) containing CD45-/34+ elements of 0.93%. The Institutional Review Board approved the study protocol and consent forms. RESULTS: All patients were successfully infused CBM plus h-AD-MSC without any untoward effects and showed 30% to 50% decreased insulin requirements with 4- to 26-fold increased serum c-peptide levels, with a mean follow-up of 2.9 months. CONCLUSION: This report describes safe and effective treatment of insulinopenic diabetics using insulin-producing h-AD-MSC plus CBM without xenogeneic materials.
PMID: 18555133 [PubMed - indexed for MEDLINE]

some interesting articles on Dr. Trivedi realy fascinating.

http://goggly.blogspot.com/2006/02/real-life-hero-of-swades.html

{ the original email which alerted me to dr. Trivedis experiments .


prakashthakrar@gmail.com
vbmenu_register("postmenu_974344", true);

external usenet poster

Posts: 1
DR H L TRIVEDI OF AHMEDABAD, GUJARAT, INDIA IS ON WAY TO CURE TYPE 1 / JUVENILE DIABETES ?
DR H L TRIVEDI OF AHMEDABAD, GUJARAT, INDIA IS ON WAY TO CURE TYPE 1 /JUVENILE DIABETES ?Here in India, ETV Gujarati telecasted interview of Dr H L Trivedi on15th August 2007.Click the link to see the news in detail:-http://www.medicaldaily.net/link.asp...Gujarat%20docsOn 17th, I contact his hospital TELEPHONICALLY & inquired about theavailability of the treatment to Diabetics; especially about my 16 yrJuvenile Diabetic only Son*. A lady named Nalinibahen, replied on hisbehalf over the telephone that I may go to there in Ahmedabad duringany Monday to Friday with prior appoint. On inquiry, She gotconfirmation that blood group of my son & of mine is equal. She toldme about the procedure that on arrival, they, through minor surgery,collect a piece of fat from my stomack & let us leave the hospital forabout 15 days. During these period, they will cultivate stem cellsfrom it. When stem cells r ready from the fat, they will call us fortreatment of my Juvenile/Type 1 Diabetic Son. She informed me overTELEPHONE that they will transplant the stem cell into lever of thepatient. After that, the patient has to let admitted for about 1month. On inquiry, she told me their charges, Rs. 1 Lac.WHAT DO U THINK ABOUT THIS NEWS WHEN SUCH TYPE OF RESEARCES ARECONTINEOUSLY GOING ON ALL OVER GLOBE ?HONEST OPINION PLEASE...!!!Prakash Thakrar, India}

Sunday, August 24, 2008

online Indian language editor

use the www.swecha.org online editor to post in Indian languages .you can use this to post on the internet and on this blog